article thumbnail

Global leaders gather at the NFCR Summit to drive breakthroughs in cancer care

News Medical Health Sciences

The 2024 National Foundation for Cancer Research (NFCR) Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted with the AIM-HI Accelerator Fund, convened the world's top experts across cancer research, biotech entrepreneurship, pharmaceuticals, investment, and patient advocacy.

article thumbnail

Selkirk Pharma introduces ClinFAST™ to expedite fill/finish for clinical trials

News Medical Health Sciences

pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the launch of ClinFAST, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SPH Plugs In: Our Favorites This Fall

BU School of Public Health Blog

Eddie Lai Eddie Lai (SPH’19), who studied healthcare management and pharmaceutical development, delivery, and access while a student at SPH, recommends the podcast Freakonomics M.D. Freakonomics M.D. with Bapu Jena, a health economist, practicing internal medicine physician, and professor of health care policy.

article thumbnail

The US relies on China for key medicines. They won't be spared from tariffs

The Hill

President Trump's tariffs in China are in place and hitting all products imported from the country including a number of pharmaceutical drugs that Americans rely upon. pharmaceutical companies turned to other manufacturing pursuits. Chinese imports account for a significant proportion of U.S. prescriptions and over the counter drugs.

article thumbnail

The Grotesque Bird Flu Scam and How Colds or Flus Should Be Treated

Mercola

the pharmaceutical industry). 30 Unfortunately, one of the most common grifts in this industry is to hype up the danger of a new disease, then have a new biotech company present a "cure" (or vaccine) for the disease and offer a large number of shares that investors eagerly buy up (spiking the price). one large study found 37.8%

article thumbnail

Drugmaker shares drop after RFK Jr. tapped to lead HHS

The Hill

Shares in several pharmaceutical and biotechnology companies have fallen since President-elect Trump announced Thursday that he had tapped vaccine skeptic Robert F. The SPDR S&P Biotech ETF, which tracks the biotech sector, has dropped 3.7 Shares in major pharmaceutical companies are down as well: Pfizer has fallen 4.6